Login Register Cart 0
Generic placeholder image

Current Nanomedicine

Editor-in-Chief

ISSN (Print): 2468-1873
ISSN (Online): 2468-1881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

An Overview of Transferosomal Technology

In Press, (this is not the final "Version of Record"). Available online 20 May, 2024
Author(s): Neha Kumari and Sumit Sharma*
Published on: 20 May, 2024

DOI: 10.2174/0124681873281058240509114133

Price: $95

Abstract

Ever since the invention of liposomes by Bangham in 1963, researchers have been fascinated by the vesicular carriers. Liposomes and niosomes have been used extensively by researchers for various routes such as oral and nasal. However, lately, it has been understood that traditional liposomes are not very significant when it comes to penetration. The use of nanovesicles in transdermal drug delivery systems has been enhanced exponentially ever since the discovery of ultra- deformable liposomes known as transfersomes or transferosomes. Transferosomes have numerous advantages, such as biocompatibility, biodegradability, flexibility, and deformability, so that they can pass through narrow constrictions. They have good entrapment efficiency and can act as a depot to sustain the release of drugs. The methods of preparation include the rotary film evaporation method, reverse phase evaporation method, vortexing sonication method, ethanol injection method, and freeze-thaw method. Transfersomes are characterized by particle size, zeta potential, polydispersity index, surface morphology, and encapsulation efficiency. Transferosomes have been successfully exploited for the enhancement of efficacy of many drugs like Hydroquinone, Itraconazole, Ivabradine, lornoxicam, minoxidil etc., via transdermal and nasal routes. The technology is easy to scale up. Consequently, it can be inferred that transfersomes are the future of transdermal drug delivery systems.

[1]
Bangham AD. Physical structure and behaviour of lipids and lipid enzymes. Adv Lipid Res 1963; 1: 65-104.
[http://dx.doi.org/10.1016/B978-1-4831-9937-5.50008-9] [PMID: 14248958]
[2]
Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an anti-HIV agent. Indian J Pharm Sci 2004; 66: 72-81.
[3]
Swarnlata S, Gunjan J, Chanchal DK, Shailendra S. Development of novel herbal cosmetic cream with Curcuma longa extract loaded transfersomes for anti-wrinkle effect. Afr J Pharm Pharmacol 2011; 5(8): 1054-62.
[4]
Kumar R, Philip A. Modified transdermal technologies: Breaking the barriers of drug permeation via skin. Trop J Pharm Res 2007; 6(1): 633-44.
[http://dx.doi.org/10.4314/tjpr.v6i1.14641]
[5]
Modi C, Bharadia P. Transfersomes: New dominants for transdermal drug delivery, Am. J PharmTech Res 2012; 2(3): 71-91.
[6]
Vyas SP, Khar RK. Targeted and controlled drug delivery. (1st ed.), Delhi: CBS Publishers 2002.
[7]
Cevc G. Isothermal lipid phase transitions. Chem Phys Lipids 1991; 57(2-3): 293-307.
[http://dx.doi.org/10.1016/0009-3084(91)90082-M] [PMID: 2054910]
[8]
Schatzlein A, Cevc G. Skin penetration by phospholipids vesicles, Transfersomes as visualized by means of the Confocal Scanning Laser Microscopy, in characterization, metabolism, and novel biological applications. AOCS Press 1995; pp. 191-209.
[9]
Vinod KR, Kumar MS, Anbazhagan S, et al. Critical issues related to transfersomes - novel vesicular system. Acta Sci Pol Technol Aliment 2012; 11(1): 67-82.
[PMID: 22230977]
[10]
Walve R, Bakliwal R, Rane R, Pawar P. Transfersomes: A surrogated carrier for transdermal drug delivery system. Int J Appl Biol Pharm Technol 2011; 2(1): 201-14.
[11]
Iskandarsyah I I, Rahmi AD, Pangesti DM. Comparison of the characteristics of transfersomes and protransfersomes containing azelaic acid. J Young Pharm 2018; 10(2s): S11-5.
[http://dx.doi.org/10.5530/jyp.2018.2s.3]
[12]
Jiang T, Wang T, Li T, et al. Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma. ACS Nano 2018; 12(10): 9693-701.
[http://dx.doi.org/10.1021/acsnano.8b03800] [PMID: 30183253]
[13]
Garg V, Singh H, Bimbrawh S, et al. Ethosomes and transfersomes: Principles, perspectives and practices. Curr Drug Deliv 2017; 14(5): 613-33.
[PMID: 27199229]
[14]
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13(1): 238-IN27.
[http://dx.doi.org/10.1016/S0022-2836(65)80093-6] [PMID: 5859039]
[15]
Singh HP, Utreja P, Tiwary AK, Jain S. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J 2009; 11(1): 54-64.
[http://dx.doi.org/10.1208/s12248-008-9078-8] [PMID: 19191031]
[16]
Szoka F Jr, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978; 75(9): 4194-8.
[http://dx.doi.org/10.1073/pnas.75.9.4194] [PMID: 279908]
[17]
Rai K, Gupta Y, Jain A, Jain SK. Transfersomes: self-optimizing carriers for bioactives. PDA J Pharm Sci Technol 2008; 62(5): 362-79.
[PMID: 19055232]
[18]
Kumar A, Adde S, Kamble R. Development and characterization of liposomal drug delivery system for nimesulide. Int J Pharm Pharm Sci 2010; 2: 87-9.
[19]
Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery. Int J Pharm 2006; 312(1-2): 53-60.
[http://dx.doi.org/10.1016/j.ijpharm.2005.12.047] [PMID: 16469460]
[20]
Harmita H, Iskandarsyah I, Afifah SF. Effect of transfersome formulation on the stability and antioxidant activity of N-acetylcysteine in anti-aging cream. Int J App Pharm 2020; 12(1): 156-62.
[http://dx.doi.org/10.22159/ijap.2020.v12s1.FF034]
[21]
AL Shuwaili AH, Rasool BKA, Abdulrasool AA, Alaa A. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Eur J Pharm Biopharm 2016; 102(February): 101-14.
[http://dx.doi.org/10.1016/j.ejpb.2016.02.013] [PMID: 26925505]
[22]
Dwiastuti R, Noegrohati S, Istyastono EP, Marchaban . Marchaban. Formulation and physical properties observations of soy lecithin liposome containing 4- n -butylresorcinol. AIP Conf Proc 2016; 2016: 160005.
[http://dx.doi.org/10.1063/1.4958598]
[23]
Piumitali B, Neeraj U, Jyotivardhan J. Transfersomes — A nanoscience in transdermal drug delivery and its clinical advancements. Int J Nanosci 2020; 19(4): 1950033.
[http://dx.doi.org/10.1142/S0219581X19500339]
[24]
Wu PS, Li YS, Kuo YC, Tsai SJ, Lin CC. Preparation and evaluation of novel transfersomes combined with the natural antioxidant resveratrol. Molecules 2019; 24(3): 600.
[http://dx.doi.org/10.3390/molecules24030600] [PMID: 30743989]
[25]
Avadhani KS, Manikkath J, Tiwari M, et al. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv 2017; 24(1): 61-74.
[http://dx.doi.org/10.1080/10717544.2016.1228718] [PMID: 28155509]
[26]
Bollareddy SR, Krishna V, Roy G, Dasari D, Dhar A, Venuganti VVK. Transfersome hydrogel containing 5-fluorouracil and etodolac combination for synergistic oral cancer treatment. AAPS PharmSciTech 2022; 23(2): 70.
[http://dx.doi.org/10.1208/s12249-022-02221-z] [PMID: 35132496]
[27]
Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta Biomembr 2004; 1663(1-2): 61-73.
[http://dx.doi.org/10.1016/j.bbamem.2004.01.006] [PMID: 15157608]
[28]
Ghanbarzadeh S, Arami S. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed Res Int 2013; 2013: 1-7.
[http://dx.doi.org/10.1155/2013/616810] [PMID: 23936825]
[29]
Thakur N, Jain P, Jain V. Formulation development and evaluation of transferosomal gel. J Drug Deliv Ther 2018; 8(5): 168-77.
[http://dx.doi.org/10.22270/jddt.v8i5.1826]
[30]
Pravalika R, Bindu EH, Iswariya VT, Battu S. Formulation and evaluation of transferosomes loaded with an anti-hyperlipidemic drug. J Sci Res Rep 2021; 65-71.
[http://dx.doi.org/10.9734/jsrr/2021/v27i630402]
[31]
Shaji J, Lal M. Preparation, optimization and evaluation of transferosomal formulation for enhanced transdermal delivery of a COX-2 inhibitor. Int J Pharm Pharm Sci 2014; 6: 467-77.
[32]
Jamadar A, Peram R, Chandrasekhar N. Formulation, optimization, and evaluation of ultradeformable nanovesicles for effective topical delivery of hydroquinone. J Pharm Innov 2022; 18(7): 1-19.
[http://dx.doi.org/10.1007/s12247-022-09657-7]
[33]
Zheng W, Fang X, Wang L, Zhang Y. Preparation and quality assessment of itraconazole transfersomes. Int J Pharm 2012; 436(1-2): 291-8.
[http://dx.doi.org/10.1016/j.ijpharm.2012.07.003] [PMID: 22796030]
[34]
Shah JP, Khan AI, Maurya R, Shukla AK. Formulation development and evaluation of Transferosomal drug delivery for effective treatment of acne. Advance Pharmaceutical Journal 2019; 4(1): 26-34.
[http://dx.doi.org/10.31024/apj.2019.4.1.4]
[35]
Varia U, Joshi D, Jadeja M, Katariya H, Detholia K, Soni V. Development and evaluation of ultradeformable vesicles loaded transdermal film of boswellic acid. Futur J Pharm Sci 2022; 8(1): 39.
[http://dx.doi.org/10.1186/s43094-022-00428-2]
[36]
Jangdey MS, Gupta A, Saraf S, Saraf S. Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation. Artif Cells Nanomed Biotechnol 2017; 45(7): 1452-62.
[http://dx.doi.org/10.1080/21691401.2016.1247850] [PMID: 28050929]
[37]
Balata GF, Faisal MM, Elghamry HA, Sabry SA. Preparation and characterization of ivabradine HCl transfersomes for enhanced transdermal delivery. J Drug Deliv Sci Technol 2020; 60: 101921.
[http://dx.doi.org/10.1016/j.jddst.2020.101921]
[38]
Singh S, Kanere M, Jain A, Mehta P. Formulation development and evaluation of transfersomes of econazole for effective fungal treatment. Int J Adv Sci Res 2021; 12(03 Suppl 1): 96-101.
[http://dx.doi.org/10.55218/JASR.s1202112310]
[39]
Saitejaswi R, Swapna S, Madhu Babu A, Vasudha B. Formulation and evaluation of lornoxicam loaded transfersome gelFormulation and evaluation of lornoxicam loaded transfersome gel EJBPS 2016; 3(31): 144-50.
[40]
Kanshide A, Peram R, Chandrasekhar N. Formulation, optimization, and antioxidant evaluation of tetrahydrocurcumin-loaded ultradeformable nanovesicular cream. J Pharm Innov 2022; 18: 980-98.
[http://dx.doi.org/10.1007/s12247-022-09696-0]
[41]
Ramezani V, Honarvar M, Seyedabadi M, Karimollah A, Ranjbar AM, Hashemi M. Formulation and optimization of transfersome containing minoxidil and caffeine. J Drug Deliv Sci Technol 2018; 44: 129-35.
[http://dx.doi.org/10.1016/j.jddst.2017.12.003]
[42]
Chaudhari P, Lokhande S. Formulation and evaluation of nabumetone loaded transfersomal gel. IJPSR 2023; 14(3): 1300-11.
[43]
Shashi T, Abdul N, Prakash G, Ankit A, Vinay H, Shruthi N. Formulation and evaluation of dexamethasone loaded transfersomal gel by modified hand shaking method. WJPPS 2019; 8(8): 1181-94.
[44]
Mahmood S, Chatterjee B, Mandal UK. Pharmacokinetic evaluation of the synergistic effect of raloxifene loaded transfersomes for transdermal delivery. J Drug Deliv Sci Technol 2021; 63: 102545.
[http://dx.doi.org/10.1016/j.jddst.2021.102545]
[45]
Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers. AAPS PharmSciTech 2013; 14(1): 133-40.
[http://dx.doi.org/10.1208/s12249-012-9904-2] [PMID: 23242556]
[46]
Marwah H, Garg T, Rath G, Goyal AK. Development of transferosomal gel for trans-dermal delivery of insulin using iodine complex. Drug Deliv 2016; 23(5): 1636-44.
[http://dx.doi.org/10.3109/10717544.2016.1155243] [PMID: 27187718]
[47]
Salem HF, Kharshoum RM, Abou-Taleb HA, Naguib DM. Nanosized transferosome-based intranasal in situ gel for brain targeting of resveratrol: formulation, optimization, in vitro evaluation, and in vivo pharmacokinetic study. AAPS PharmSciTech 2019; 20(5): 181.
[http://dx.doi.org/10.1208/s12249-019-1353-8] [PMID: 31049748]
[48]
Rabia S, Khaleeq N, Batool S, et al. Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: Passive targeting via topical route. Nanomedicine 2020; 15(2): 183-203.
[http://dx.doi.org/10.2217/nnm-2019-0320] [PMID: 31916472]
[49]
Rasheed MS, Ansari SF, Shahzadi I. Formulation, characterization of glucosamine loaded transfersomes and in vivo evaluation using papain induced arthritis model. Sci Rep 2022; 12(1): 19813.
[http://dx.doi.org/10.1038/s41598-022-23103-1] [PMID: 36396950]
[50]
Ahad A, Al-Saleh AA, Al-Mohizea AM, et al. Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate. Saudi Pharm J 2017; 25(7): 1040-6.
[http://dx.doi.org/10.1016/j.jsps.2017.01.006] [PMID: 29158713]
[51]
Opatha SAT, Titapiwatanakun V, Boonpisutiinant K, Chutoprapat R. Preparation, characterization and permeation study of topical gel loaded with transfersomes containing asiatic acid. Molecules 2022; 27(15): 4865.
[http://dx.doi.org/10.3390/molecules27154865] [PMID: 35956816]
[52]
Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics 2018; 10(1): 26.
[http://dx.doi.org/10.3390/pharmaceutics10010026] [PMID: 29473897]
[53]
Ahmed TA. Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett–Burman design and characterization. J Liposome Res 2015; 25(1): 1-10.
[http://dx.doi.org/10.3109/08982104.2014.950276] [PMID: 25148294]
[54]
Nayak D, Tawale RM, Aranjani JM, Tippavajhala VK. Formulation, optimization and evaluation of novel ultra-deformable vesicular drug delivery system for an anti-fungal drug. AAPS PharmSciTech 2020; 21(5): 140.
[http://dx.doi.org/10.1208/s12249-020-01681-5] [PMID: 32419032]
[55]
Salimi A, Sharif B, Nazarian A, Esfahani G. Formulation, characterization and in vitro/ex-vivo evaluation of trolamine salicylate - loaded transfersomes as transdermal drug delivery carriers. Int J Pharm Sci Res 2018; 9(9): 3725-31.
[56]
Abdelmonem R, Hamed RR, Abdelhalim SA, ElMiligi MF, El-Nabarawi MA. Formulation and characterization of cinnarizine targeted aural transfersomal gel for vertigo treatment: A pharmacokinetic study on rabbits. Int J Nanomedicine 2020; 15: 6211-23.
[http://dx.doi.org/10.2147/IJN.S258764] [PMID: 32904111]
[57]
Mazhar D, Haq NU, Zeeshan M, et al. Preparation, characterization, and pharmacokinetic assessment of metformin HCl loaded transfersomes co-equipped with permeation enhancer to improve drug bioavailability via transdermal route. J Drug Deliv Sci Technol 2023; 84: 104448.
[http://dx.doi.org/10.1016/j.jddst.2023.104448]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy